Speaker illustration

Doctor Philip Sarajlic

Karolinska Institute, Stockholm (Sweden)

Member of:

European Society of Cardiology
Heart Failure Association

Dr. Philip Sarajlic received his MD degree from the Karolinska Institute in Stockholm, Sweden. He is currently serving as a research scientist in the translational cardiology team at the Department of Medicine at Karolinska University Hospital. His main area of interest is computational cardiology, with a primary focus on research and development of bioinformatics and artificial intelligence solutions in medical settings. In addition, he is managing intercontinental projects in applied machine learning in the fields of heart failure phenotyping, identification of cardiovascular risk factors, and detection of intervention side effects. As a frequently invited reviewer of manuscript submissions to high-impact cardiovascular journals, he stays up-to-date with recent developments and contributes to quality assurance in the area.

Incidence, associated outcomes and predictors of upper gastrointestinal bleeding following acute myocardial infarction - a SWEDEHEART based nationwide cohort study

Event: ESC Congress 2021 - The Digital Experience

Topic: Epidemiology, Prognosis, Outcome

Session: Latest Science in ACS


Validation of machine learning-derived heart failure phenotypes from the United States PINNACLE registry in the Swedish heart failure registry

Event: Heart Failure 2021

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic Heart Failure - Epidemiology, Prognosis, Outcome


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb